Mark Foundation Grantees at SITC 2026

Each year, the Society for Immunotherapy of Cancer (SITC) brings together leading researchers to share updates from the forefront of cancer immunology at its annual meeting. This year, numerous Mark Foundation for Cancer Research grantees are among the meeting’s session chairs, presenters, and awardees. Here are a few of the presentations we are excited to attend:

Thursday, November 5 – Pre-Conference Program

3:10-4:15 PM

New Agents in Development and Emerging Technologies Session IV: Emerging Technologies – Incorporation into Clinical Trials
Presenter: Justin Eyquem, PhD, University of California, San Francisco
Presentation: In vivo and Solid Tumor CAR-T Cell Therapies
Location: Sheraton – 2nd Level – Valley of the Sun Ballroom

12:00-1:30 PM

Early Career Scientist Meet-the-Expert Lunch
Career Paths for Physician Scientists – Tina Cascone, MD, PhD, The University of Texas MD Anderson Cancer Center
Navigating Academia as Junior Faculty (as MD or PhD) – Amy E. Moran, PhD, Oregon Health & Science University
Location: Sheraton – 2nd Level – Encanto AB

2:30-5:05 PM

Grant Writing Workshop Session I: Grant Writing Essentials
Presenter: Greg M. Delgoffe, PhD, University of Pittsburgh
Presentation: Funding Your Research Through Industry Collaboration

Location: Sheraton – 2nd Level – Encanto AB

7:25-8:10 PM

Launching Biotech Startups: Funding, Pitching, Partnerships – Financing and Partnerships Panel
Panelist: Tullia C. Bruno, PhD, University of Pittsburgh
Location: Phoenix Convention Center – 100 Level – 120D

Friday, November 6

8:35-9:10 AM

KEYNOTE: Richard V. Smalley Memorial Award and Lectureship
Speaker: Catherine J. Wu, MD, Dana-Farber Cancer Institute
Address: Getting Off the Rollercoaster: Personalized Cancer Vaccines Come of Age
Location: Phoenix Convention Center, North Building, 300 Level, Halls BC

9:40-11:45 AM

Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future
Co-chair: Catherine J. Wu, MD, Dana-Farber Cancer Institute
Presenter: Darrell J. Irvine, PhD, The Scripps Research Institute
Presentation: Updates on Clinical Results from the AMPLIFY-7P Study of a Lymph Node-Targeted Kras Vaccine
Location: Phoenix Convention Center – North Building – 300 Level – Halls BC

1:45-3:25 PM

Session 106a: Combination Therapies Involving Cell Therapy
Co-chair: Michael Birnbaum, PhD, Massachusetts Institute of Technology
Co-chair: Yvonne Chen, PhD, University of California, Los Angeles
Location: Phoenix Convention Center – North Building – 300 Level – Halls BC

1:45-3:25 PM

Session 106c: Immunosenescence
Co-chair and presenter: Guido Kroemer, MD, PhD, University of Paris Cité
Presentation: An Actionable, Age-Related Plasma Biomarker Involved in Lung Carcinogenesis
Presenter: Sandra S. McAllister, PhD, Brigham & Women’s Hospital
Presentation: How Age Shapes Breast Cancer Immunity, Therapeutic Response, and Outcomes
Location: Phoenix Convention Center – West Building-300 Level – 301BC

Saturday, November 7

9:20-11:00 AM

Session 202: Spatial Biology to the Forefront: Cellular Interactions within Cancer Expand our Insights in Immune Oncology
Co-chair: Ido Amit, PhD, Weizmann Institute of Science
Co-chair: Tullia C. Bruno, PhD, University of Pittsburgh
Presenter: Tina Cascone, MD, PhD, The University of Texas MD Anderson Cancer Center
Presentation: Integrated Multiomic Spatial Profiling of Neoadjuvant Immunotherapy Response in Non-Small Cell Lung Cancer
Location: Phoenix Convention Center – North Building – 300 Level – Halls BC

11:00 AM-12:00 PM

Session 203: Hot Topic Symposium: External Factors Contributing to Immunotherapy Response
Co-chair and presenter: Greg M. Delgoffe, PhD, University of Pittsburgh
Presentation: Postprandial Metabolism and its Potential to Enhance Immunotherapy Responses
Co-chair: Jennifer L. McQuade, MD, JMQ Oncology Advisors LLC
Location: Phoenix Convention Center – North Building – 300 Level – Halls BC

3:30-4:50 PM

Session 206a: New Avenues in Myeloid Cells
Presenter: Ido Amit, PhD, Weizmann Institute of Science
Presentation: Leveraging Single-Cell Technologies to Engineer the Immune System – 

Presenter: Mikala Egeblad, PhD, Cold Spring Harbor Laboratory
Presentation: Neutrophils as Architects of the Tumor Microenvironment: From Vascular Occlusion to Metastasis 

Location: Phoenix Convention Center – North Building – 300 Level – Halls BC

5:20-6:40 PM

Session 207a: Sex-specific Factors that Influence Immune Fitness and Response to Immunotherapy
Co-chair and presenter: Sherene Loi, PhD, Peter MacCallum Cancer Centre
Presentation: Breast Cancer Anti-Tumour Immunity and Reproductive History
Co-chair: Amy E. Moran, PhD, Oregon Health & Science University
Phoenix Convention Center – West Building-300 Level – 301A

5:20-6:40 PM

Session 207c: Hot and Cold Tumors
Co-chair and presenter: Brian Brown, PhD, Icahn School of Medicine at Mount Sinai
Presentation: Identifying Determinants of Hot and Cold Tumors by AI-Assisted Perturb-Map
Location: Phoenix Convention Center – North Building-300 Level – Hall A

5:20-6:40 PM

Session 207d: Cellular Therapies
Co-chair and presenter: Justin Eyquem, PhD, University of California, San Francisco
Presentation: Ex Vivo and In Vivo Genome Editing to Reprogram T Cell Function
Co-chair: Michel Sadelain, MD, PhD,
 Memorial Sloan Kettering Cancer Center
Location: Phoenix Convention Center – North Building – 300 Level – Halls BC

Sunday, November 8

8:15-9:40 AM

Session 301: Presidential Session
Expert Discussant: Greg M. Delgoffe, PhD, University of Pittsburgh
Location: Phoenix Convention Center – North Building-300 Level – Hall A

Back to all